True Wealth Design, LLC Uro Gen Pharma Ltd. Transaction History
True Wealth Design, LLC
- $284 Billion
- Q2 2025
A detailed history of True Wealth Design, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, True Wealth Design, LLC holds 16 shares of URGN stock, worth $307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 178
91.01%
Holding current value
$307
Previous $1.97 Million
88.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding URGN
# of Institutions
148Shares Held
44MCall Options Held
146KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$83.7 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$73.6 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$61.6 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$44.2 Million0.17% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$42.2 Million0.27% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $437M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...